Ascendis Pharma A/s · NASDAQ:ASND
Westfield Capital Management Co LP reported a 8.48% stake in Ascendis Pharma A/s (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Westfield Capital Management Co LP reported a 8.48% stake in Ascendis Pharma A/s, 5,185,696 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 8.48%
- Shares
- 5,185,696
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Westfield Capital Management Company, L.P. | 8.48% | 5,185,696 |
Source
Related
- Ascendis Pharma A/s
- Westfield Capital Management Co LP
- Ascendis Pharma A/s shareholders
- Schedule 13G/A · Westfield Capital Management Co LP · Feb 11, 2025
- Schedule 13G/A · Westfield Capital Management Co LP · Feb 10, 2025
- Form 4 · Bodenhoff Mads · Sep 9, 2026
- Form 4 · Holtug Lars · Sep 3, 2026
- Form 4 · Bienaime Jean Jacques · Aug 18, 2026
- Form 4 · Smith Scott Thomas · Jun 2, 2026
- Form 4 · Bienaime Jean Jacques · Jun 1, 2026